A chitosan-dipotassium orthophosphate hydrogel for the delivery of Doxorubicin in the treatment of osteosarcoma

Download

Full text for this resource is not available from the Research Repository.

Export

Ta, Hang T, Dass, Crispin R, Larson, Ian, Choong, Peter F. M and Dunstan, David E (2009) A chitosan-dipotassium orthophosphate hydrogel for the delivery of Doxorubicin in the treatment of osteosarcoma. Biomaterials, 30 (21). pp. 3605-3613. ISSN 0142-9612

Abstract

The current management of primary osteosarcoma (OS) and its secondary metastasis is limited by the lack of an efficient drug delivery system. Herewe report an in situ gelling chitosan/dipotassium orthophosphate hydrogel system designed to directly deliver the frontline chemotherapeutic agent (Doxorubicin) in a sustained time period to tumor sites. A significant reduction of both primary and secondary OS in a clinically relevant orthotopic model was measured when doxorubicin was administered with the hydrogel. This hydrogel delivery system also reduced cardiac and dermal toxicity of Doxorubicin in mice. The results obtained from this study demonstrate the potential application of a biodegradable hydrogel technology as an anti-cancer drug delivery system for successful chemotherapy.

Dimensions Badge

Altmetric Badge

Item type	Article
URI	https://vuir.vu.edu.au/id/eprint/7582
DOI	10.1016/j.biomaterials.2009.03.022
Official URL	http://dx.doi.org/10.1016/j.biomaterials.2009.03.0...
Subjects	Historical > Faculty/School/Research Centre/Department > School of Biomedical and Health Sciences Historical > FOR Classification > 1112 Oncology and Carcinogenesis Historical > SEO Classification > 9201 Clinical Health (Organs, Diseases and Abnormal Conditions)
Keywords	ResPubID21878. chitosan, orthophosphate, drug delivery, hydrogel, osteosarcoma, bone cancer, chemotherapy, Doxorubicin, tumours
Citations in Scopus	125 - View on Scopus
Download/View statistics	View download statistics for this item